Header Logo

Connection

ANITA DESWAL to Middle Aged

Back to Details
This is a "connection" page, showing publications ANITA DESWAL has written about Middle Aged.
ANITA DESWAL
Connection Strength
0.989
Middle Aged
  1. Associations of SGLT2i with Cardiorenal Outcomes Among Diabetics with Prostate Cancer on Hormone Therapy. Cardiovasc Drugs Ther. 2025 12; 39(6):1343-1352.
    View in: PubMed
    Score: 0.053
  2. Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma. Haematologica. 2022 07 01; 107(7):1555-1566.
    View in: PubMed
    Score: 0.045
  3. Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction. Int J Obes (Lond). 2020 07; 44(7):1561-1567.
    View in: PubMed
    Score: 0.039
  4. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.031
  5. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.030
  6. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.027
  7. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012 Mar 13; 59(11):998-1005.
    View in: PubMed
    Score: 0.022
  8. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
    View in: PubMed
    Score: 0.021
  9. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan; 4(1):53-8.
    View in: PubMed
    Score: 0.020
  10. Predicting quality of life in veterans with heart failure: the role of disease severity, depression, and comorbid anxiety. Behav Med. 2010 Apr-Jun; 36(2):70-6.
    View in: PubMed
    Score: 0.019
  11. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009 Jul 28; 54(5):422-8.
    View in: PubMed
    Score: 0.018
  12. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol. 2007 Jul 03; 50(1):32-6.
    View in: PubMed
    Score: 0.016
  13. Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-up. Am Heart J. 2007 Apr; 153(4):515-22.
    View in: PubMed
    Score: 0.016
  14. Racial variations in quality of care and outcomes in an ambulatory heart failure cohort. Am Heart J. 2006 Aug; 152(2):348-54.
    View in: PubMed
    Score: 0.015
  15. Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection. Circ Cardiovasc Imaging. 2026 Jun; 19(6):e019610.
    View in: PubMed
    Score: 0.015
  16. Value of Myocardial Strain in Assessing Cardiac Masses: A Case Report. Methodist Debakey Cardiovasc J. 2026; 22(1):30-33.
    View in: PubMed
    Score: 0.014
  17. Novel risk score for predicting acute cardiovascular and cerebrovascular events after chest radiotherapy in patients with breast or lung cancer. Eur J Prev Cardiol. 2026 Mar 13; 33(4):513-525.
    View in: PubMed
    Score: 0.014
  18. In HFrEF, adding digitoxin to standard care reduced a composite of death or first worsening HF hospitalization at a median 36 mo. Ann Intern Med. 2026 Jan; 179(1):JC8.
    View in: PubMed
    Score: 0.014
  19. Bayesian Learning to Reduce Cardiac Risk of Patients With Locally Advanced Non-Small Cell Lung Cancer Based on Personalized Radiation Therapy Prescription. Int J Radiat Oncol Biol Phys. 2026 Jul 01; 125(3):949-958.
    View in: PubMed
    Score: 0.014
  20. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J. 2005 Dec; 150(6):1233-9.
    View in: PubMed
    Score: 0.014
  21. Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J. 2025 10 22; 46(40):4090-4101.
    View in: PubMed
    Score: 0.014
  22. Radiation Doses to Cardiac Substructures Predict Elevation in High-sensitivity Cardiac Troponin T Levels in Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 2026 Mar 15; 124(4):1124-1136.
    View in: PubMed
    Score: 0.014
  23. Cardiovascular Outcomes in Patients With Cancer Undergoing Cardiac Implantable Electronic Device Implantation. Pacing Clin Electrophysiol. 2025 11; 48(11):1309-1319.
    View in: PubMed
    Score: 0.014
  24. Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancer. Oncologist. 2025 Aug 04; 30(8).
    View in: PubMed
    Score: 0.014
  25. Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and noncardiac vascular disease. J Card Fail. 2005 Apr; 11(3):206-12.
    View in: PubMed
    Score: 0.014
  26. GLP-1 Receptor Agonist in Nonobese Patients with Type 2 Diabetes Mellitus and Heart Failure with Preserved Ejection Fraction. J Card Fail. 2025 07; 31(7):989-1001.
    View in: PubMed
    Score: 0.013
  27. Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis. Cancer Immunol Res. 2024 Aug 01; 12(8):964-987.
    View in: PubMed
    Score: 0.013
  28. Use of positron emission tomography for the diagnosis of immune-checkpoint inhibitor| myocarditis. J Nucl Cardiol. 2024 Sep; 39:101909.
    View in: PubMed
    Score: 0.013
  29. Limitations of apical sparing pattern in cardiac amyloidosis: a multicentre echocardiographic study. Eur Heart J Cardiovasc Imaging. 2024 05 31; 25(6):754-761.
    View in: PubMed
    Score: 0.013
  30. Trends of Cardiovascular Disease-Related Mortality in Breast Cancer in the United States From 1999 to 2019. Am J Cardiol. 2024 06 15; 221:110-112.
    View in: PubMed
    Score: 0.013
  31. Evaluation of Midodrine Utilization in Patients with Cancer and Heart Failure. Cardiovasc Drugs Ther. 2025 06; 39(3):553-562.
    View in: PubMed
    Score: 0.012
  32. Cardiovascular safety profile of taxanes and vinca alkaloids: 30 years FDA registry experience. Open Heart. 2021 12; 8(2).
    View in: PubMed
    Score: 0.011
  33. Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis. Circulation. 2021 11 02; 144(18):1521-1523.
    View in: PubMed
    Score: 0.011
  34. Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial. Chest. 2001 Aug; 120(2):453-9.
    View in: PubMed
    Score: 0.010
  35. Geographical Differences in Cardiovascular Comorbidities and Outcomes of COVID-19 Hospitalized Patients in the USA. Cardiology. 2021; 146(4):481-488.
    View in: PubMed
    Score: 0.010
  36. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation. 2001 Apr 24; 103(16):2055-9.
    View in: PubMed
    Score: 0.010
  37. Inflammatory Myositis in Cancer Patients Receiving Immune Checkpoint Inhibitors. Arthritis Rheumatol. 2021 05; 73(5):866-874.
    View in: PubMed
    Score: 0.010
  38. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
    View in: PubMed
    Score: 0.010
  39. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020 03; 13(3):e006513.
    View in: PubMed
    Score: 0.010
  40. Readmissions after Acute Kidney Injury during Left Ventricular Assist Device Implantation Hospitalization. Am J Nephrol. 2020; 51(3):172-181.
    View in: PubMed
    Score: 0.009
  41. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
    View in: PubMed
    Score: 0.009
  42. Acute Kidney Injury With Ventricular Assist Device Placement: National Estimates of Trends and Outcomes. Am J Kidney Dis. 2019 11; 74(5):650-658.
    View in: PubMed
    Score: 0.009
  43. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.009
  44. Implantable Ventricular Assist Device Use and Outcomes in People With End-Stage Renal Disease. J Am Heart Assoc. 2018 07 06; 7(14).
    View in: PubMed
    Score: 0.008
  45. Effectiveness of NPs and PAs in managing diabetes and cardiovascular disease. JAAPA. 2018 Jul; 31(7):39-45.
    View in: PubMed
    Score: 0.008
  46. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.008
  47. Trends in Left Ventricular Assist Device Implantation and Associated Mortality Among Patients With and Without ESRD. Am J Kidney Dis. 2018 10; 72(4):620-622.
    View in: PubMed
    Score: 0.008
  48. De Novo Heart Failure After Kidney Transplantation: Trends in Incidence and Outcomes. Am J Kidney Dis. 2018 08; 72(2):223-233.
    View in: PubMed
    Score: 0.008
  49. Health Care Resource Utilization for Outpatient Cardiovascular Disease and Diabetes Care Delivery Among Advanced Practice Providers and Physician Providers in Primary Care. Popul Health Manag. 2018 06; 21(3):209-216.
    View in: PubMed
    Score: 0.008
  50. Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. Am J Cardiol. 2017 06 15; 119(12):2030-2034.
    View in: PubMed
    Score: 0.008
  51. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circ Heart Fail. 2016 08; 9(8).
    View in: PubMed
    Score: 0.007
  52. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
    View in: PubMed
    Score: 0.007
  53. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
    View in: PubMed
    Score: 0.007
  54. N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2016 Feb 16; 133(7):631-8.
    View in: PubMed
    Score: 0.007
  55. Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone. Circ Heart Fail. 2015 Nov; 8(6):1052-8.
    View in: PubMed
    Score: 0.007
  56. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 2015 May 19; 131(20):1763-71.
    View in: PubMed
    Score: 0.007
  57. Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction. Circ Heart Fail. 2015 May; 8(3):533-41.
    View in: PubMed
    Score: 0.007
  58. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
    View in: PubMed
    Score: 0.007
  59. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
    View in: PubMed
    Score: 0.007
  60. Alcohol consumption and risk of heart failure: the Atherosclerosis Risk in Communities Study. Eur Heart J. 2015 Apr 14; 36(15):939-45.
    View in: PubMed
    Score: 0.007
  61. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40.
    View in: PubMed
    Score: 0.007
  62. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail. 2014 Aug; 2(4):412-21.
    View in: PubMed
    Score: 0.006
  63. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013 Dec 18; 310(23):2533-43.
    View in: PubMed
    Score: 0.006
  64. Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study. Circ Heart Fail. 2014 Jan; 7(1):123-30.
    View in: PubMed
    Score: 0.006
  65. Association between preoperative diuretic use and in-hospital outcomes after cardiac surgery. Cardiovasc Ther. 2013 Oct; 31(5):291-7.
    View in: PubMed
    Score: 0.006
  66. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10.
    View in: PubMed
    Score: 0.006
  67. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013 Mar 27; 309(12):1268-77.
    View in: PubMed
    Score: 0.006
  68. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012 Dec 13; 367(24):2296-304.
    View in: PubMed
    Score: 0.006
  69. Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. Am Heart J. 2012 Nov; 164(5):763-770.e3.
    View in: PubMed
    Score: 0.006
  70. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012 Oct; 18(10):792-8.
    View in: PubMed
    Score: 0.006
  71. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013 Sep 01; 167(5):1912-7.
    View in: PubMed
    Score: 0.006
  72. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail. 2012 Mar 01; 5(2):152-9.
    View in: PubMed
    Score: 0.005
  73. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail. 2012 Mar; 18(3):183-93.
    View in: PubMed
    Score: 0.005
  74. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol. 2013 Jun 20; 166(2):394-8.
    View in: PubMed
    Score: 0.005
  75. New predictive models of heart failure mortality using time-series measurements and ensemble models. Circ Heart Fail. 2011 Jul; 4(4):456-62.
    View in: PubMed
    Score: 0.005
  76. Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med. 2011 Mar 03; 364(9):797-805.
    View in: PubMed
    Score: 0.005
  77. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J. 2011 Mar; 161(3):567-73.
    View in: PubMed
    Score: 0.005
  78. The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study. Am J Epidemiol. 2010 Oct 01; 172(7):781-9.
    View in: PubMed
    Score: 0.005
  79. Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure. Vasc Health Risk Manag. 2010 Aug 09; 6:449-55.
    View in: PubMed
    Score: 0.005
  80. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
    View in: PubMed
    Score: 0.005
  81. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010 Feb 01; 105(3):373-7.
    View in: PubMed
    Score: 0.005
  82. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail. 2009 May; 15(4):293-9.
    View in: PubMed
    Score: 0.004
  83. The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. Am J Surg. 2008 Nov; 196(5):720-5.
    View in: PubMed
    Score: 0.004
  84. Decreasing body temperature predicts early rehospitalization in congestive heart failure. J Card Fail. 2008 Aug; 14(6):489-96.
    View in: PubMed
    Score: 0.004
  85. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail. 2008 Sep; 14(7):590-5.
    View in: PubMed
    Score: 0.004
  86. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest. 2003 Mar; 123(3):716-24.
    View in: PubMed
    Score: 0.003
  87. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 2002 Dec; 8(6):390-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.